HIGHLIGHTS
- who: Yuki Kojima from the Department of Medical Oncology, National Cancer Center Hospital, u20111u20111, Tsukiji, Chuou2011Ku, Tokyo, u20110045, Japan have published the research: Changes in HER3 expression profiles between primary and recurrent gynecological cancers, in the Journal: (JOURNAL)
- what: The authors evaluated HER3 expression in matched-paired specimens taken from gynecological cancer patients at initial and recurrent diagnosis to evaluate HER3 as a promising biomarker for overcoming treatment failure and improving patient outcomes. The authors report the change in HER3 expression in gynecological tumor tissues of patients between initial and recurrent diagnosis.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.